This announcement is a separate document:
康弘药业：2023年度独立董事述职报告（张宇）
Kanghong Pharmaceutical: 2023 Independent Director Debriefing Report (Zhang Yu)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
08:01
Australia's Treasurer Chalmers has appointed Marnie Baker as a member of the Reserve Bank of Australia's monetary policy committee.
08:00
The Japanese stock market opens: Nikkei 225 Index rises by 0.2%, SoftBank Group and Nintendo increase by over 1%.
Nikkei 2250.00%
07:55
China Securities Co.,Ltd.: As the commercialization of AI gradually enters the implementation phase, the industry is expected to accelerate further.
China Securities Co.,Ltd.-3.03%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.